283 results on '"Medof, M. Edward"'
Search Results
52. Differential contribution of complement receptor C5aR in myeloid and non-myeloid cells in chronic ethanol-induced liver injury in mice
53. CD55 Is Essential for CD103+Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity
54. Decay Accelerating Factor Can Control T Cell Differentiation into IFN-γ-Producing Effector Cells via Regulating Local C5a-Induced IL-12 Production1
55. Membrane Complement Receptors Specific for Bound Fragments of C3
56. Shear Stress–Dependent Downregulation of the Adhesion-G Protein–Coupled Receptor CD97 on Circulating Leukocytes upon Contact with Its Ligand CD55
57. Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells
58. A Novel Role for CD55 in Granulocyte Homeostasis and Anti-Bacterial Host Defense
59. Circulating immune complexes in neurologic disease
60. Interaction of Decay-Accelerating Factor with Echovirus 7
61. The Intrinsic Complement Regulator Decay-Accelerating Factor Modulates the Biological Response to Vascular Injury
62. Deletion of either CD55 or CD97 ameliorates arthritis in mouse models
63. An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice
64. Donor Deficiency of Decay-Accelerating Factor Accelerates Murine T Cell-Mediated Cardiac Allograft Rejection
65. Locally produced C5a binds to T cell–expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis
66. IFN-γ and IL-17 Production in Experimental Autoimmune Encephalomyelitis Depends on Local APC–T Cell Complement Production
67. Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T Cells
68. Anti-C5 Antibody Treatment Ameliorates Weakness in Experimentally Acquired Myasthenia Gravis
69. Interaction of Decay-Accelerating Factor with Coxsackievirus B3
70. Decay Accelerating Factor Can Control T Cell Differentiation into IFN-γ-Producing Effector Cells via Regulating Local C5a-Induced IL-12 Production
71. Structure-based Mapping of DAF Active Site Residues That Accelerate the Decay of C3 Convertases
72. Differential Contributions of C3, C5, and Decay-Accelerating Factor to Ethanol-Induced Fatty Liver in Mice
73. Locally produced complements are mediators of B7CD28 and CD40CD40L costimulation during cognate APCT cell interactions
74. The Role of Decay-accelerating Factor as a Receptor for Helicobacter pylori and a Mediator of Gastric Inflammation
75. Decay-accelerating factor modulates induction of T cell immunity
76. Decay-Accelerating Factor Deficiency Increases Susceptibility to Dextran Sulfate Sodium-Induced Colitis: Role for Complement in Inflammatory Bowel Disease
77. Respective Roles of Decay-Accelerating Factor and CD59 in Circumventing Glomerular Injury in Acute Nephrotoxic Serum Nephritis
78. A Corresponding Tyrosine Residue in the C2/Factor B Type A Domain Is a Hot Spot in the Decay Acceleration of the Complement C3 Convertases
79. Proprotein interaction with the GPI transamidase
80. Lipid Protein Interactions: The Assembly of CD1d1 with Cellular Phospholipids Occurs in the Endoplasmic Reticulum
81. Decay-accelerating Factor (DAF), Complement Receptor 1 (CR1), and Factor H Dissociate the Complement AP C3 Convertase (C3bBb) via Sites on the Type A Domain of Bb
82. Comparative efficiencies of C-terminal signals of native glycophosphatidylinositol (GPI)-anchored proproteins in conferring GPI-anchoring
83. Characterization of the Active Sites in Decay-Accelerating Factor
84. C5a receptor-mediated production of IL-8 by the human retinal pigment epithelial cell line, ARPE-19
85. Properties of exogenously added GPI-anchored proteins following their incorporation into cells
86. Upregulation of DAF (CD55) on orbital fibroblasts by cytokines. Differential effects of TNF-ß and TNF-a
87. Decay-Accelerating Factor in Tears of Contact Lens Wearers and Patients with Contact Lens-Associated Complications
88. Cooperation Between Decay-Accelerating Factor and Membrane Cofactor Protein in Protecting Cells from Autologous Complement Attack
89. Release of complement regulatory proteins from ocular surface cells in infections
90. Glycosylphosphatidylinositol-anchor intermediates associate with Triton-insoluble membranes in subcellular compartments that include the endoplasmic reticulum
91. Protein Transfer of Glycosyl-Phosphatidylinositol (GPI)-Modified Murine B7–1 and B7–2 Costimulators
92. Leukemia Arising out of Paroxysmal Nocturnal Hemoglobinuria
93. Complementary Recognition of Alternative Pathway Activators by Decay-Accelerating Factor and Factor H
94. The Cytoplasmic Juxtamembrane Domain of the Epidermal Growth Factor Receptor Contains a Novel Autonomous Basolateral Sorting Determinant
95. Accumulation of glucosaminyl(acyl)phosphatidylinositol in an S3 HeLa subline expressing normal dolicholphosphomannose synthase activity
96. Cell‐surface engineering with GPI‐anchored proteins
97. PIG‐A, DAF and proto‐oncogene expression in paroxysmal nocturnal haemoglobinuria‐associated acute myelogenous leukaemia blasts
98. Purified GPI-Anchored CD4DAF as a Receptor for HIV-Mediated Gene Transfer
99. Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland
100. Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-?1 signaling and induction of Foxp3+ regulatory T cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.